Skip to main content
SpringerLink
Log in

Drug-eluting endovascular therapy cost effective in UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. costs in British pounds based on 2015/2016 NHS England Tariff, Hospital Episodes Statistics data, and current BMS, DCB and DES device prices

Reference

  • Katsanos K, et al. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK. BMJ Open 6: e011245, No. 5, 9 May 2016. Available from: URL: http://dx.doi.org/10.1136/bmjopen-2016-011245

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug-eluting endovascular therapy cost effective in UK. PharmacoEcon Outcomes News 754, 11 (2016). https://doi.org/10.1007/s40274-016-3081-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3081-6

Search

Navigation